Regent Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,375	Closed	-$307K	–	210
2017 Q2	$307K	Hold	3,375	–	–	0.11%	171
2017 Q1	$296K	Hold	3,375	–	–	0.11%	167
2016 Q4	$280K	Sell	3,375 -75	-2%	-$6.45K	0.14%	156
2016 Q3	$319K	Hold	3,450	–	–	0.17%	143
2016 Q2	$268K	Hold	3,450	–	–	0.15%	153
2016 Q1	$285K	Hold	3,450	–	–	0.16%	147
2015 Q4	$361K	Hold	3,450	–	–	0.19%	131
2015 Q3	$363K	Hold	3,450	–	–	0.2%	128
2015 Q2	$472K	Hold	3,450	–	–	0.24%	116
2015 Q1	$430K	Hold	3,450	–	–	0.22%	122
2014 Q4	$312K	Sell	3,450 -150	-4%	-$12.5K	0.16%	146
2014 Q3	$260K	Hold	3,600	–	–	0.13%	159
2014 Q2	$224K	Sell	3,600 -190	-5%	-$11.5K	0.11%	170
2014 Q1	$259K	Buy	3,790 +190	+5%	+$14K	0.14%	158
2013 Q4	$253K	Hold	3,600	–	–	0.14%	151
2013 Q3	$260K	Sell	3,600 -175	-5%	-$11.6K	0.17%	138
2013 Q2	$210K	Buy	+3,775	New	+$235K	0.16%	142